These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26463987)

  • 1. A Review of Systemic Vasodilators in Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery.
    Mills KI; Costello JM; Almodovar MC
    Curr Vasc Pharmacol; 2016; 14(1):29-36. PubMed ID: 26463987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.
    Avila-Alvarez A; Del Cerro Marin MJ; Bautista-Hernandez V
    Curr Vasc Pharmacol; 2016; 14(1):37-47. PubMed ID: 26463986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical and Evidence-Based Benefit of Afterload Reduction in the Postoperative Pediatric Heart.
    DiNardo JA; Almodovar MC
    Curr Vasc Pharmacol; 2016; 14(1):24-8. PubMed ID: 26463988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.
    Ferrer-Barba A; Gonzalez-Rivera I; Bautista-Hernandez V
    Curr Vasc Pharmacol; 2016; 14(1):48-57. PubMed ID: 26463985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Manipulation of Peripheral Vascular Resistance in Single Ventricle Patients (Stages I, II, and III of Palliation).
    Schwartz SM; Floh AA; Laussen PC
    Curr Vasc Pharmacol; 2016; 14(1):58-62. PubMed ID: 26463984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged infusion of varied doses of dopexamine hydrochloride for circulatory failure after cardiac surgery.
    Santman FW; Thomas SM; Hoskins B
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):13. PubMed ID: 2577706
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thematic Issue: Pharmacologic Strategies with Afterload Reduction in Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.
    Bautista-Hernandez V; Almodovar MC
    Curr Vasc Pharmacol; 2016; 14(1):3-4. PubMed ID: 26642871
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular and Molecular Mechanisms of Low Cardiac Output Syndrome after Pediatric Cardiac Surgery.
    Bautista-Hernandez V; Karamanlidis G; McCully JD; Del Nido PJ
    Curr Vasc Pharmacol; 2016; 14(1):5-13. PubMed ID: 26463990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery.
    Santman FW
    J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):568-72. PubMed ID: 1358247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the hemodynamic effects of amrinone and sodium nitroprusside in infants after cardiac surgery.
    Bailey JM; Miller BE; Kanter KR; Tosone SR; Tam VK
    Anesth Analg; 1997 Feb; 84(2):294-8. PubMed ID: 9024017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of Post-Operative Low Cardiac Output Syndrome.
    Epting CL; McBride ME; Wald EL; Costello JM
    Curr Vasc Pharmacol; 2016; 14(1):14-23. PubMed ID: 26463989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Manipulation of Peripheral Vascular Resistance in Special Clinical Situations after Pediatric Cardiac Surgery.
    Moga MA; Nguyen N; Mazwi ML; Costello JM
    Curr Vasc Pharmacol; 2016; 14(1):63-72. PubMed ID: 26463983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of dopexamine hydrochloride in patients with low cardiac output after cardiac surgery.
    Du Gres B; Flamens C; Gruner MC
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):16. PubMed ID: 2577709
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Levosimendan in Postoperative Setting After Surgical Repair of Congenital Heart Disease in Children.
    Amiet V; Perez MH; Longchamp D; Boulos Ksontini T; Natterer J; Plaza Wuthrich S; Cotting J; Di Bernardo S
    Pediatr Cardiol; 2018 Jan; 39(1):19-25. PubMed ID: 28884218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the automated management of hypertension after open heart surgery. The relevance of the initial systemic vascular resistance as index for predicting hemodynamic response to computer-controlled nitroprusside infusion.
    Pomer S; Elert O; Satter P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):207-13. PubMed ID: 6715091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilators. A re-evaluation of their role in heart failure.
    Stevenson LW; Fonarow G
    Drugs; 1992 Jan; 43(1):15-36. PubMed ID: 1372857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making a choice of inotropes and vasodilators in clinical situations.
    Hug CC
    J Card Surg; 1990 Sep; 5(3 Suppl):272-7. PubMed ID: 2133856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.